Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +3.15% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.21 | N/A | +3.15% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed cautious optimism about the company's performance despite supply chain challenges. They emphasized their commitment to growth and innovation.
Management highlighted strong demand in key markets.
They noted ongoing challenges in supply chain but remain focused on growth.
Future investments are aimed at enhancing product offerings.
Agilent Technologies reported a slight earnings beat, but the stock fell by 0.93% in reaction. Investors may be concerned about the lack of revenue details and forward guidance. The cautious tone from management regarding supply chain issues could also have contributed to the stock's decline.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SPIRE INC
Nov 22, 2021